Zydus Cadila, an Ahmedabad-based pharmaceutical major, has posted a rise of 15 per cent in its consolidated net profit at Rs 230 crore for the first quarter ended June 30, 2011 as against Rs 199 crore during the same period last fiscal.
The company's consolidated sales during the period rose by 11 per cent to Rs 1,189 crore from Rs 1,068 crore in the corresponding quarter of the previous year. In the domestic formulations market, the company launched 20 new products, including line extensions, of which 6 products were the first to be launched in India. During the quarter the company’s formulation business in Europe increased by 22% and in Brazil it increased by 21%.
